← Leaderboards
Jenna Guthmiller
University Of Chicago
$1,932,976
Attributed
$1,932,976
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $694K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,932,976 · 4
By mechanism
DP2$1,354,521 · 1
R00$248,999 · 1
R21$225,953 · 1
K99$103,503 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Albert S. Bendelac$31,264,054
- Anita S. Chong$25,087,826
- Anna Di Rienzo$12,488,198
- Karen Leigh Edelblum$8,422,013
- Roshni Roy Chowdhury$433,592
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesMemory B-LymphocyteB-Cell Antigen ReceptorBindingSpecificityAntigensAntibody ResponseHemagglutininB-LymphocytesAffinityMonoclonal AntibodiesVaccinationMemory RecallInfluenzavirusInfluenza A Virus, H1n1 SubtypeResponseImmunityHeadPandemic DiseaseExposure ToEpitopesAdultExperimental StudyImmunize
Grant awards (6)
Shifting immunodominance of humoral immunity against influenza viruses$468,000
DP2 · FY2025 · AI · contact PI
Defining human xenoglycan-specific B cells$225,953
R21 · FY2025 · AI · contact PI
Shifting immunodominance of humoral immunity against influenza viruses$436,669
DP2 · FY2024 · AI · contact PI
Shifting immunodominance of humoral immunity against influenza viruses$449,852
DP2 · FY2023 · AI · contact PI
Investigating the development and clonal dynamics of broadly neutralizing B cells against influenza viruses$248,999
R00 · FY2022 · AI · contact PI
Investigating the development and clonal dynamics of broadly neutralizing B cells against influenza viruses$103,503
K99 · FY2021 · AI · contact PI